Skip to main content

Table 3 Significant differences between cases and controls for some variants

From: Genomic susceptibility to gastric cancer in Northwest Iran: population-based and case–control studies

Variant

  

Cases

Controls

P value

Odds ratio (95% CI)

rs1050631

      
 

Genotype (No.)

CC (reference)

88

71

  
  

CT

55

70

 < 0.0001

3.37 (2.16–5.27)

  

TT

7

9

0.019

3.4 (1.22–9.49)

  

CT+TT

62

79

 < 0.0001

3.374 (2.19–5.19)

rs12983273

      
 

Genotype (No.)

CC (reference)

128

113

  
  

CT+TT

22

37

0.031

1.9 (1.1–3.4)

 

Allele (Freq.)

C (reference)

0.923

0.863

  
  

T

0.077

0.137

0.02

1.91 (1.1–3.3)

rs1695

      
 

Genotype (No.)

AA (reference)

56

74

  
  

AG+GG

94

76

0.036

0.612 (0.39–0.97)

 

Allele (Freq.)

A (reference)

0.627

0.703

  
  

G

0.373

0.297

0.047

0.708 (0.5–0.99)

rs2274223

      
 

Genotype (No.)

AA (reference)

34

47

  
  

GG

36

24

0.035

0.482 (0.24–0.95)

rs2292832

      
 

Genotype (No.)

TT (reference)

68

45

  
  

TC

58

65

0.046

1.693 (1.01–2.84)

  

CC

27

40

0.01

2.239 (1.21–4.15)

  

TC+CC

85

105

0.01

1.867 (1.16–3)

 

Allele (Freq.)

T (reference)

0.647

0.517

  
  

C

0.353

0.483

0.001

1.712 (1.23–2.38)

rs2505901

      
 

Genotype (No.)

TT (reference)

88

71

  
  

TC+CC

62

79

0.0497

1.58 (1.0005–2.5)

 

Allele (Freq.)

T (reference)

0.717

0.637

  
  

C

0.283

0.363

0.0366

1.44 (1.02–2.04)

rs33927012

      
 

Allele (Freq.)

T (reference)

0.933

0.97

  
  

C

0.067

0.03

0.0412

0.43 (0.19–0.97)

rs3745469

      
 

Genotype (No.)

GG (reference)

80

97

  
  

GA+AA

70

53

0.046

0.62 (0.39–0.99)

 

Allele (Freq.)

G (reference)

0.72

0.79

  
  

A

0.28

0.21

0.047

0.68 (0.47–0.99)

rs6505162

      
 

Genotype (No.)

AA (reference)

19

34

  
  

AC

73

60

0.02

0.46 (0.24–0.89)

  

AC+CC

131

116

0.025

0.5 (0.27–0.91)